CD274 and cancer: We note in passing that the Mutant 4 which we identified could be useful in cancer therapy as an scFv as was a previously reported high-affinity anti-PD-L1 protein (a mutant form of PD-1, which bound PD-L1 with a KD of 110 pM59).